Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 856785-75-6
2. 1,4,3-oxathiazinane 4,4-dioxide
3. Misetionamide [inn]
4. Gp2250
5. Gp-2250
6. 489tq24fc1
7. 1,4,3-oxathiazine, Tetrahydro-, 4,4-dioxide
8. Unii-489tq24fc1
9. 1,4lambda6,3-oxathiazinane-4,4-dione
10. Misetionamide [who-dd]
11. Misetionamide (usan/inn)
12. Misetionamide [usan]
13. Schembl223495
14. Chembl5314425
15. 1,4,5-oxathiazinane-4,4-dioxide
16. Mfcd30530652
17. 1,4lambda,3-oxathiazinane-4,4-dione
18. Da-75559
19. Hy-147280
20. Cs-0542676
21. D12792
Molecular Weight | 137.16 g/mol |
---|---|
Molecular Formula | C3H7NO3S |
XLogP3 | -0.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 63.8 |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 156 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
31
PharmaCompass offers a list of Misetionamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Misetionamide manufacturer or Misetionamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Misetionamide manufacturer or Misetionamide supplier.
PharmaCompass also assists you with knowing the Misetionamide API Price utilized in the formulation of products. Misetionamide API Price is not always fixed or binding as the Misetionamide Price is obtained through a variety of data sources. The Misetionamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GP-2250 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GP-2250, including repackagers and relabelers. The FDA regulates GP-2250 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GP-2250 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GP-2250 supplier is an individual or a company that provides GP-2250 active pharmaceutical ingredient (API) or GP-2250 finished formulations upon request. The GP-2250 suppliers may include GP-2250 API manufacturers, exporters, distributors and traders.
GP-2250 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GP-2250 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GP-2250 GMP manufacturer or GP-2250 GMP API supplier for your needs.
A GP-2250 CoA (Certificate of Analysis) is a formal document that attests to GP-2250's compliance with GP-2250 specifications and serves as a tool for batch-level quality control.
GP-2250 CoA mostly includes findings from lab analyses of a specific batch. For each GP-2250 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GP-2250 may be tested according to a variety of international standards, such as European Pharmacopoeia (GP-2250 EP), GP-2250 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GP-2250 USP).